Papapetropoulos Spyridon
Insider CIK 1832694 · NEUP President and CEO, Director · ADMS Director · LPCN Director · VIGL Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NEUP Neuphoria Therapeutics Inc | A Award deriv | 2025-08-27 | 2025-09-02 | 34,559 | $8.27 | $285.8K | 74,088 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2025-06-04 | 2025-06-05 | 1,764 | $3.20 | $5.6K | 7,174 | SEC↗ |
| NEUP Neuphoria Therapeutics Inc | A Award deriv | 2025-04-16 | 2025-04-18 | 270,000 | $5.16 | $1.39M | 282,529 | SEC↗ |
| NEUP Neuphoria Therapeutics Inc | A Award deriv | 2025-04-16 | 2025-05-19 | 27,000 | $5.16 | $139.3K | 39,529 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 1,764 | $7.05 | $12.4K | 5,410 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2023-05-10 | 2023-05-12 | 30,000 | $0.27 | $8.1K | 62,000 | SEC↗ |
| LPCN Lipocine Inc. | P Buy | 2022-11-22 | 2022-11-28 | 21,739 | $0.47 | $10.2K | 21,739 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | M Exercise deriv | 2022-11-18 | 2022-11-22 | 300 | — | $0 | 149,604 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | M Exercise | 2022-11-18 | 2022-11-22 | 300 | $1.89 | $567 | 4,300 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | S Sale | 2022-11-18 | 2022-11-22 | 300 | $14.00 | $4.2K | 4,000 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 22,000 | $0.92 | $20.2K | 32,000 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | P Buy | 2022-05-03 | 2022-05-04 | 4,000 | $3.40 | $13.6K | 4,000 | SEC↗ |
| LPCN Lipocine Inc. | A Award deriv | 2022-04-11 | 2022-04-12 | 10,000 | $1.16 | $11.6K | 10,000 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 75,500 | — | $0 | 75,500 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | D To issuer deriv | 2021-11-24 | 2021-11-24 | 10,000 | — | $0 | 0 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | D To issuer deriv | 2021-11-24 | 2021-11-24 | 20,000 | — | $0 | 0 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | U Tender | 2021-11-24 | 2021-11-24 | 20,975 | — | $0 | 0 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2021-06-02 | 2021-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award | 2021-06-02 | 2021-06-04 | 5,000 | — | $0 | 20,975 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | P Buy | 2021-03-11 | 2021-03-15 | 5,975 | $5.06 | $30.2K | 15,975 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award deriv | 2020-11-22 | 2020-11-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ADMS Adamas Pharmaceuticals Inc | A Award | 2020-11-22 | 2020-11-24 | 10,000 | — | $0 | 10,000 | SEC↗ |